Search results
Order by most recent / most popular / relevance
Results: 1-6 of 6
2013 challenges for the communications sector
- Bird & Bird
- -
- Belgium, China, Czech Republic, Finland, France, Germany, Hungary, Netherlands, Spain, Sweden, United Kingdom
- -
- February 12 2013
The 4G spectrum auctions dominate across the featured countries while developments relating to cookie regulation and net neutrality feature
Corporate restructuring to minimise risks
- Bird & Bird
- -
- European Union, Germany, United Kingdom
- -
- January 18 2013
Many automotive parts suppliers in Europe are mid-sized (family owned) businesses with inflexible and outdated corporate structures that are not
Customary usage in the trade gains importance in determining infringement
- Bird & Bird
- -
- Germany, United Kingdom
- -
- January 9 2013
There is a constellation (or fact pattern) in patent cases which at first may sound unlikely, but which upon closer inspection proves to be both
Commission approves proposed acquisition of English Welsh & Scottish Railway Holdings by Deutsche Bahn, subject to conditions
- Bird & Bird
- -
- European Union, Germany, United Kingdom
- -
- January 3 2008
The Commission has cleared under the EU Merger Regulation the proposed acquisition of English Welsh & Scottish Railway Holdings (EWS) by Deutsche Bahn (DB
Commission approves proposed acquisition of three Yamaha distributors by Yamaha
- Bird & Bird
- -
- European Union, Germany, Poland, United Kingdom
- -
- January 3 2008
The Commission has cleared under the EU Merger Regulation the proposed acquisition of Mitsui Motor Polskia SP.Z.O.O. of Poland, Yamaha Motor Deutschland GMBH of Germany and Yamaha Motor UK Ltd by Yamaha Motor Europe N.V., part of the Yamaha Motor Corporation of Japan
New ECJ reference in relation to supplementary protection certificates for medicinal products
- Bird & Bird
- -
- European Union, Germany, United Kingdom
- -
- December 20 2007
The latest reference to the ECJ under Council Regulation (EEC) No 179892 concerning the creation of a supplementary protection certificate for medicinal products, which establishes the scheme by which supplementary protection certificates (SPCs) enable de facto patent term extension of up to 5 years to be secured for pharmaceuticals, concerns the time limit for filing an application for such an SPC
Current Search
Suggested Facets
Author
Jurisdiction
- Belgium (1)
- China (1)
- Czech Republic (1)
- European Union (4)
- Finland (1)
- France (1)
- Hungary (1)
- Netherlands (1)
